These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 30543614)
1. Reducing the impact of the impending myopia epidemic in New Zealand. Petty AD; Wilson G N Z Med J; 2018 Dec; 131(1487):80-85. PubMed ID: 30543614 [TBL] [Abstract][Full Text] [Related]
2. An evidence-based update on myopia and interventions to retard its progression. Leo SW; Young TL J AAPOS; 2011 Apr; 15(2):181-9. PubMed ID: 21596297 [TBL] [Abstract][Full Text] [Related]
3. A Review of Current Concepts of the Etiology and Treatment of Myopia. Cooper J; Tkatchenko AV Eye Contact Lens; 2018 Jul; 44(4):231-247. PubMed ID: 29901472 [TBL] [Abstract][Full Text] [Related]
4. Current approaches to myopia control. Leo SW; Curr Opin Ophthalmol; 2017 May; 28(3):267-275. PubMed ID: 28212157 [TBL] [Abstract][Full Text] [Related]
5. Biological Mechanisms of Atropine Control of Myopia. Upadhyay A; Beuerman RW Eye Contact Lens; 2020 May; 46(3):129-135. PubMed ID: 31899695 [TBL] [Abstract][Full Text] [Related]
6. Prevention and Management of Myopia and Myopic Pathology. Saw SM; Matsumura S; Hoang QV Invest Ophthalmol Vis Sci; 2019 Feb; 60(2):488-499. PubMed ID: 30707221 [TBL] [Abstract][Full Text] [Related]
7. Interventions to Reduce Myopia Progression in Children. Tay SA; Farzavandi S; Tan D Strabismus; 2017 Mar; 25(1):23-32. PubMed ID: 28166436 [TBL] [Abstract][Full Text] [Related]
8. A Review of Myopia Control with Atropine. Tran HDM; Tran YH; Tran TD; Jong M; Coroneo M; Sankaridurg P J Ocul Pharmacol Ther; 2018 Jun; 34(5):374-379. PubMed ID: 29715053 [TBL] [Abstract][Full Text] [Related]
9. Update on Myopia Control: The US Perspective. Rhee MK Eye Contact Lens; 2022 Mar; 48(3):105-109. PubMed ID: 35192563 [TBL] [Abstract][Full Text] [Related]
14. The Role of Atropine Eye Drops in Myopia Control. Grzybowski A; Armesto A; Szwajkowska M; Iribarren G; Iribarren R Curr Pharm Des; 2015; 21(32):4718-30. PubMed ID: 26350533 [TBL] [Abstract][Full Text] [Related]
15. Practical applications to modify and control the development of ametropia. Sankaridurg PR; Holden BA Eye (Lond); 2014 Feb; 28(2):134-41. PubMed ID: 24310242 [TBL] [Abstract][Full Text] [Related]
16. [Stabilizing effectiveness of orthokeratology and long-term minute-concentration atropine therapy in myopia (draft report)]. Verzhanskaya TY; Tarutta EP Vestn Oftalmol; 2017; 133(5):43-48. PubMed ID: 29165412 [TBL] [Abstract][Full Text] [Related]
17. What Public Policies Should Be Developed to Deal with the Epidemic of Myopia? Morgan IG Optom Vis Sci; 2016 Sep; 93(9):1058-60. PubMed ID: 27525535 [TBL] [Abstract][Full Text] [Related]
18. Public Health Burden and Potential Interventions for Myopia. Modjtahedi BS; Ferris FL; Hunter DG; Fong DS Ophthalmology; 2018 May; 125(5):628-630. PubMed ID: 29681290 [No Abstract] [Full Text] [Related]
19. Myopia, an underrated global challenge to vision: where the current data takes us on myopia control. Holden B; Sankaridurg P; Smith E; Aller T; Jong M; He M Eye (Lond); 2014 Feb; 28(2):142-6. PubMed ID: 24357836 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of atropine 1% in children with low myopia. Yi S; Huang Y; Yu SZ; Chen XJ; Yi H; Zeng XL J AAPOS; 2015 Oct; 19(5):426-9. PubMed ID: 26228967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]